Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prokinetic maintenance therapy for functional dyspepsia: real-world study
ChiCTR2100042166Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of domperidone, mosapride, itopride and cinitapride in functional dyspepsia (FD) (3 arms), sponsored by Union Hospital. Primary endpoint: Overall effective rate. Started Feb 2021; status: recruiting.
02
Drugs
domperidonemosaprideitopridecinitapride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2100042166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042166.